EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis

Roberts, Graham; Pfaar, Oliver; A. Akdiş, Cezmi; J. Ansotegui, Ignacio; R. Durham, Stephen; Gerth van Wijk, Roy; Halken, Susanne; Larenas‐Linnemann, Désirée; Pawankar, Ruby; Pitsios, Constantinos; Sheikh, Aziz; Worm, Margitta; Arasi, Stefania; A. Calderón, Moisés; Cingi, Cemal; Dhami, Sangeeta; Fauquert, J.-L.; Hamelmann, Eckard; W. Hellings, Peter; Jacobsen, Lars; F. Knol, Edward; Lin, Shyh‐Jye; Maggina, Paraskevi; Mösges, Ralph; N. G. Oude Elberink, J.; B. Pajno, G.; A. Pastorello, Elide; Penagos, Martín; Rotiroti, Guiseppina; B. Schmidt‐Weber, Carsten; Timmermans, Frans; Tsilochristou, Olympia; Varga, E.‐M.; N. Wilkinson, J.; B. Williams, Andrew; Zhang, Luo; Agache, Ioana; Angier, Elizabeth; Fernández‐Rivas, Montserrat; Jutel, Marek; Lau, Susanne; van Ree, Ronald; Ryan, Dermot; J. Sturm, Gunter; Muraro, Antonella

doi:10.1111/all.13317

Public

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis

Published in Allergy • Sep 23, 2017

Authors:

Graham Roberts

Oliver Pfaar

Cezmi A. Akdiş

Abstract

Allergic rhinoconjunctivitis (AR) is an allergic disorder of the nose and eyes affecting about a fifth of the general population. Symptoms of AR can be controlled with allergen avoidance measures and pharmacotherapy. However, many patients continue to have ongoing symptoms and an impaired quality of...

Subject

Medicine

Allergen immunotherapy

Immunology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!